Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1093
https://www.valueinhealthjournal.com/article/S1098-3015(16)32459-7/fulltext
Title :
Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32459-7&doi=10.1016/j.jval.2016.09.1093
First page :
A534
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1023